title: Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study.
authors.affiliation: Clinical Investigation Center in Biotherapy, Institut national de la santé et de la recherche médicale, Centre Investigation Clinique-1431, Fédération Hospitalo-Universitaire INCREASE, University Hospital of Besançon, and Department of Rheumatology, University Hospital of Besançon, and Department of Therapeutics and EA 4266 "Pathogens and Inflammation", Structure Fédérative de Recherche 4234, University of Franche-Comté, Besançon, France; etoussirot@chu-besancon.fr.
authors.forename: Éric
authors.initials: É
authors.lastname: Toussirot
authors.affiliation: Department of Rheumatology, Hospital of Saint-Brieuc, Saint-Brieuc, France;
authors.forename: Antoine
authors.initials: A
authors.lastname: Martin
authors.affiliation: Department of Rheumatology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France;
authors.forename: Martin
authors.initials: M
authors.lastname: Soubrier
authors.affiliation: Department of Internal Medicine, Hospital of Abbeville, Abbeville, France;
authors.forename: Serge
authors.initials: S
authors.lastname: Redeker
authors.affiliation: Department of Internal Medicine, University Hospital of Cochin, Paris, France.
authors.forename: Alexis
authors.initials: A
authors.lastname: Régent
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011111:Polymyalgia Rheumatica / Q000175:diagnosis / Q000188:drug therapy*; D011446:Prospective Studies; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; C502936:tocilizumab